Novartis Farmacéutica SA de CV in Consumer Health (Mexico)

March 2015 | 3 pages | ID: N75112A3A5DEN
Euromonitor International Ltd

Abstracts

Novartis Farmaceútica SA de CV is the Mexican subsidiary of multinational pharmaceutical behemoth Novartis AG. The company has historically been active in several health-related segments. In April 2014, Novartis AG announced a deal with rival pharmaceutical power GlaxoSmithKline (GSK) to streamline its product offerings and concentrate on oncology treatments, eye care and pharmaceuticals.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric OTC Healthcare, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Novartis Farmaceútica SA de CV: Key Facts
Summary 2 Novartis Farmaceútica SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Novartis Farmaceútica SA de CV: Competitive Position 2014